tiprankstipranks
Advertisement
Advertisement

RZLT Stock Latest News

Rezolute: Buy Rating Reaffirmed as FDA Catalysts Support CGM‑Driven Upside, Price Target Maintained at $6
RatingsRezolute: Buy Rating Reaffirmed as FDA Catalysts Support CGM‑Driven Upside, Price Target Maintained at $6
6h ago
RZLT
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity
PremiumTipRanks Newswire
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity
1M ago
PTN
CRNX
Rezolute price target raised to $11, named a Best Idea at Guggenheim
PremiumThe Fly
Rezolute price target raised to $11, named a Best Idea at Guggenheim
2M ago
RZLT
Yum! Brands upgraded, Chipotle downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Yum! Brands upgraded, Chipotle downgraded: Wall Street’s top analyst calls
3M ago
T
CAG
Rezolute price target raised to $14 from $10 at Maxim
PremiumThe Fly
Rezolute price target raised to $14 from $10 at Maxim
3M ago
RZLT
Rezolute price target raised to $6 from $5 at Wedbush
PremiumThe FlyRezolute price target raised to $6 from $5 at Wedbush
3M ago
RZLT
Rezolute upgraded to Outperform from Market Perform at Citizens
Premium
The Fly
Rezolute upgraded to Outperform from Market Perform at Citizens
3M ago
RZLT
Rezolute price target raised to $6 from $5 at BTIG
Premium
The Fly
Rezolute price target raised to $6 from $5 at BTIG
3M ago
RZLT
Rezolute price target raised to $14 from $10 at Maxim
PremiumThe Fly
Rezolute price target raised to $14 from $10 at Maxim
3M ago
RZLT
Rezolute Reports Positive Phase 3 Data for Ersodetug
PremiumCompany Announcements
Rezolute Reports Positive Phase 3 Data for Ersodetug
3M ago
8K
RZLT
Rezolute provides interim update on ersodetug study
PremiumThe Fly
Rezolute provides interim update on ersodetug study
3M ago
RZLT
Rezolute price target raised to $10 from $4 at Maxim
PremiumThe Fly
Rezolute price target raised to $10 from $4 at Maxim
3M ago
RZLT
Rezolute: Buy Rating Reaffirmed as Analyst Keeps $5 Price Target on Pipeline Momentum and Phase 3 Data
PremiumRatingsRezolute: Buy Rating Reaffirmed as Analyst Keeps $5 Price Target on Pipeline Momentum and Phase 3 Data
3M ago
RZLT
Rezolute reports Q3 EPS (16c), consensus (17c)
Premium
The Fly
Rezolute reports Q3 EPS (16c), consensus (17c)
3M ago
RZLT
Rezolute Shares Expanded Phase 3 sunRIZE Data With FDA
Premium
Company Announcements
Rezolute Shares Expanded Phase 3 sunRIZE Data With FDA
4M ago
8K
RZLT
Rezolute Buy Rating Reiterated as CGM Data Offset Phase 3 Miss; $5 Price Target Maintained
PremiumRatings
Rezolute Buy Rating Reiterated as CGM Data Offset Phase 3 Miss; $5 Price Target Maintained
4M ago
RZLT
Rezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026
PremiumThe Fly
Rezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026
4M ago
RZLT
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
PremiumThe Fly
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
5M ago
GM
AMD
Wedbush upgrades Rezolute as worst case scenario seems unlikely for cHI
PremiumThe Fly
Wedbush upgrades Rezolute as worst case scenario seems unlikely for cHI
5M ago
RZLT
Rezolute upgraded to Outperform from Neutral at Wedbush
PremiumThe FlyRezolute upgraded to Outperform from Neutral at Wedbush
5M ago
RZLT
Rezolute Prepares FDA Submission After sunRIZE Trial Review
Premium
Company Announcements
Rezolute Prepares FDA Submission After sunRIZE Trial Review
5M ago
8K
RZLT
Rezolute provides update on sunRIZE study following Type B meeting with FDA
Premium
The Fly
Rezolute provides update on sunRIZE study following Type B meeting with FDA
5M ago
RZLT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >